` SYNACT (SynAct Pharma AB) vs OMX Stockholm 30 Comparison - Alpha Spread

S
SYNACT
vs
O
OMX Stockholm 30

Over the past 12 months, SYNACT has underperformed OMX Stockholm 30, delivering a return of -6% compared to the OMX Stockholm 30's +33% growth.

Stocks Performance
SYNACT vs OMX Stockholm 30

Loading
SYNACT
OMX Stockholm 30
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SYNACT vs OMX Stockholm 30

Performance Gap Between SYNACT and OMXS30
LOCKED
Unlock

Performance By Year
SYNACT vs OMX Stockholm 30

Loading
SYNACT
OMX Stockholm 30
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
SynAct Pharma AB vs Peers

OMX Stockholm 30
SYNACT
RYI
AVGR
BROG
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

SynAct Pharma AB
Glance View

Market Cap
954.6m SEK
Industry
Biotechnology

SynAct Pharma AB engages in the development of pharmaceutical drugs for the treatment of inflammatory diseases. The company is headquartered in Lund, Skane. The company went IPO on 2016-07-11. The firm is located in Lund, Sweden. The company develops medicines for acute impairment in inflammatory diseases. The firm's drug candidate AP1189 is intended for the treatment of arthritis including psoriasis arthritis.

SYNACT Intrinsic Value
LOCKED
Unlock
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett